2016. ASCO Annual Meeting – Cost per Median Overall Month of Survival in Multiple Myeloma Patients with ≥3 Lines of Therapy or Were Double Refractory

Maiese EM, Dimova M, Baio G, Makin C. Cost per Median Overall Month of Survival in Multiple Myeloma Patients with ≥3 Lines of Therapy or Were Double Refractory. J Clin Oncol. 34, 2016 (suppl; abstr 8057). Presented at: ASCO 2016; June 6, 2016; Chicago, IL, USA.